Latest News You are here:HomeOur servicesList of servicesInflammatory Bowel Disease ServiceLatest News 17th May 2024 – TGA approval of etrasimod (Velsipity®) for ulcerative colitis 18th January 2024 – TGA approval of ustekinumab biosimilar (Wezlana®) for Crohn’s disease and ulcerative colitis 3rd January 2024 – PBS listing of ustekinumab (Stelara®) for fistulising Crohn’s disease 1st December 2023 – PBS listing of upadacitinib (Rinvoq®) for Crohn’s disease 1st May 2023 – PBS listing of upadacitinib (Rinvoq®), ozanimod (Zeposia®) and ustekinumab (Stelara®) for ulcerative colitis